This non-specificity is also shown similarly in the case of amyloid-β or tau proteins because these proteins could increase in all the conditions of neurodegeneration, not only in dementia but in PD and even amyotrophic lateral sclerosis [133–135]. This evidence concerns the gene MAPT and Parkinson disease.